NCT06202092

Brief Summary

Osteoarthritis (OA) is a progressive chronic disease with the loss of articular cartilage. It is now well recognized that the progression of the disease involves erosion of the cartilage, osteochondral inflammatory damage, and bone distortion. Many recent medical procedures provide treatment through improving symptoms through tissue regeneration and restoring homeostasis to local cells. Unlike bone, articular cartilage is rather recalcitrant to regenerate. Honey is a natural material contain 200 distinct chemical compounds in honey including a wide range of phenolic compounds that have antioxidant, bacteriostatic, antimicrobial, and anti-inflammatory properties. Honey was found to increase the printability and chondrogenic potential of a naturally derived bioink are the main formulations used as hydrogel for Articular Cartilage (AC) regeneration due to their similarity to chondral tissue in terms of morphological and mechanical properties. Design: Double blinded, Randomized control trial. Methods: 50 osteoarthritic patients will be evaluated to be allocated after they match the inclusion criteria then randomized to two groups, group A for Phonophoresis using Honey as coupling media with conventional physical therapy program, group B for ultrasound with regular gel as a coupling media with conventional physical therapy. Outcome measures: the primary outcome measure will be the thickness of the cartilage will be measured using diagnostic ultrasound, the secondary outcome measure will be knee pain measured by the visual analog scale (VAS) and Western Ontario and McMaster Universities OA Index (WOMAC) pain subscale, also functional mobility which will be measured using the stiffness and physical function subscales of the total WOMAC. All will be measured 1 day before starting the procedures and after 4 weeks of the intervention 3sessions/week.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

1 month

First QC Date

December 30, 2023

Last Update Submit

February 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • cartilage thickness

    knee joint cartilage thickness

    4 weeks

Secondary Outcomes (2)

  • Pain severity

    4 weeks

  • Functional mobility

    4 weeks

Study Arms (2)

Honey Group

EXPERIMENTAL

will receive phonophoresis with honey and conventional physical therapy treatment in the form of transcutaneous electrical nerve stimulation (TENS) current and exercise . The parameters of the application of phonophoresis will be the continuous modality, 1 MHz frequency, intensity of 1 or 1.5 W/cm2, and an application time of 10 minutes

Device: PhonophoresisProcedure: conventional physiotherapy

Control Group

OTHER

will receive ultrasound therapy with gel media and the same conventional physical therapy treatment (control group)

Device: UltrasoundProcedure: conventional physiotherapy

Interventions

Ultrasound using honey as a media over the knee joint

Honey Group

ultrasound using gel as a media over the knee joint

Control Group

TENS, Strengthening, and stretching exercises

Control GroupHoney Group

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • bilateral mild-to-moderate medial tibiofemoral Osteoarthritis

You may not qualify if:

  • rheumatologic conditions such as:
  • rheumatoid arthritis,
  • severe knee OA,
  • thrombosis of the lower limbs,
  • patients who had physiotherapy treatment of the knee in the previous 6 months,
  • a history of injections in the knee joint during the last 6 months,
  • balance disorders,
  • neuropathy or sensory disorders,
  • skin damage around the knee,
  • previous surgery on the knee joint, or a previous fracture of the lower extremity with knee joint involvement.
  • Patients will be also excluded if they have any contraindications or precautions for the use of ultrasound (e.g., infection, heart problems, pacemaker, metal implants, open epiphysis, pregnancy, thrombophlebitis, or impaired sensation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Jazan University

Jizan, Gizan, 45142, Saudi Arabia

RECRUITING

Jazan University

Jizan, Gizan, 45142, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

PhonophoresisUltrasonography

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Drug Administration RoutesDrug TherapyTherapeuticsDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Abdelrahman Elsayegh, Associate professor

    University of Jazan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohamed M Ahmed, Assistant Professor

CONTACT

Azza A Alareefy, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Fifty patients with bilateral knee OA whose ages range from 40 to 65 years and body mass indexes between 25 to 35 kg/m2, who will meet the eligibility criteria and will be randomized into two treatment groups using computer-generated numbers in sealed envelopes. The patients will be blinded to the group allocation
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

December 30, 2023

First Posted

January 11, 2024

Study Start

January 15, 2024

Primary Completion

February 15, 2024

Study Completion

March 15, 2024

Last Updated

February 21, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations